Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association 2026 Congress 12 May
Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® Cream in Adults with Moderate Atopic Dermatitis 07 May
